Outsourcing: Analysis and developments of contract service providers to the pharmaceutical and biotechnology industries - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Outsourcing
Contract manufacturing organizations (CMOs) and contract research organizations (CROs). Global sourcing of pharma ingredients and services. Trends and challenges for the biopharmaceutical and pharmaceutical industries.

FDA Revamps to Meet New Challenges

December 2, 2011

Pharmaceutical Technology

Added responsibilities and outside concerns prompt overhaul of agency's structure.

The Employment Outlook Brightens

December 2, 2011

Pharmaceutical Technology

Readers react to the economic turmoil of the past year and look longingly forward to 2012.

Buzz Off the Product

December 2, 2011

Pharmaceutical Technology

Cleanliness is crucial, even if zapping and trapping is necessary to reduce product contamination.

Report from Asia

December 2, 2011

Pharmaceutical Technology

Packaging is indeed headed to be a lead sector in the Asian pharmaceutical environment, but certain challenges must first be overcome.

Q&A with Deborah Tanner, Covance

December 2, 2011
Pharmaceutical Technology

A Q&A with Deborah Tanner, executive vice-president and group president of R&D laboratories at Covance, on recent industry trends.

Views from Pharma Leaders: A Year in Review and a Look Forward

December 2, 2011

Pharmaceutical Technology

Drug shortages, supply-chain security, generic-drug incursion, and flexible manufacturing models are some of the issues shaping the bio/pharma industry.

Growth for Small Pharma

November 2, 2011

Pharmaceutical Technology

Small drug companies with hopes of achieving $1 billion in sales can pursue various strategies.

Easy on the Alcohol!

November 2, 2011

Pharmaceutical Technology

Careful mixing during a product's distillation can help avert trouble from a strong concoction.

Turning around Pharmaceutical Manufacturing in the US

November 2, 2011

Pharmaceutical Technology

The authors propose a plan to keep the US pharma industry afloat and in the lead.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
Click here